Teva Launches Educational Initiative to Arm Women with Facts about Emergency Contraception
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Teva Pharma (TEVA) Comments on Stichting's Move to Exercise Call Option on Mylan (MYL); Sees as 'Unwarranted'
July 23, 2015 9:06 AM EDTTeva Pharma (NYSE: TEVA) issued the following statement regarding Stichting Preferred Shares Mylans (Nasdaq: MYL) decision to exercise its call option:
We strongly disagree with the stated analysis of Stichting Preferred Shares Mylan and its decision... More
